Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Celanese CorpCelanese Corporation Reports Q1 2026 Financial Results with $2.337 Billion in Net Sales
CDW CorpCDW Corporation Reports 9.2% Net Sales Increase to $5.68 Billion in Q1 2026
ServisFirst Bancshares, Inc.ServisFirst Bancshares Reports $83M Net Income in Q1 2026, Up from $63.2M Last Year
BGSF, INC.BGSF, Inc. Reports Revenue Decline and Improved Net Loss in Latest Financial Results
Sunrun Inc.Sunrun Inc. Reports 43% Revenue Growth to $722.2 Million in Q1 2026
Criteo S.A.Criteo Reports 6% Revenue Decline and 79% Drop in Net Income for Q1 2026
Zevia PBCZevia Reports 21.2% Revenue Growth to $46.1 Million in Q1 2026
agilon health, inc.Agilon Health Reports Q1 2026 Financial Results with Revenue Decline and Increased Net Income
INDEPENDENT BANK CORPIndependent Bank Corp. Reports 80% Increase in Net Income for Q1 2026
enVVeno Medical CorpenVVeno Medical Reports $3.8 Million Net Loss in Q1 2026, Advances enVVe System
Revolution Medicines, Inc.Revolution Medicines Reports $453.8 Million Net Loss in Q1 2026 Amid Increased R&D Spending
GOLD ROCK HOLDINGS, INC.Gold Rock Holdings Reports No Sales Revenue and Net Loss in Q1 2026
STANDARD BIOTOOLS INC.Standard BioTools Reports $21.1 Million Revenue and $127.1 Million Net Income in Q1 2026
COHERENT CORP.Coherent Corp. Reports 21% Revenue Growth to $1.81 Billion in Latest Quarter
FuboTV Inc.FuboTV Reports $1.57 Billion Revenue for Three Months Ended March 31, 2026
Tarsus Pharmaceuticals, Inc.Tarsus Pharmaceuticals Reports $162.1 Million Revenue in Q1 2026, Net Loss Improves to $7.0 Million
OMNICELL, INC.Omnicell Reports 15% Revenue Growth and Net Income Turnaround in Q1 2026
Context Therapeutics Inc.Context Therapeutics Reports $8.7 Million Net Loss in Q1 2026, Increases R&D Spending
Blue Owl Technology Finance Corp.Blue Owl Technology Finance Corp. Reports $171.3 Million Net Investment Income for Q1 2026
CASTLE BIOSCIENCES INCCastle Biosciences Reports $83.7 Million Revenue in Q1 2026, Net Loss Improves
ACCURAY INCAccuray Reports 7% Revenue Decline in Q3 Fiscal Year 2026
Pennant Group, Inc.Pennant Group Reports 36% Revenue Growth to $285.4 Million in Latest Quarter
Blue Owl Capital CorpBlue Owl Capital Corp Reports $24.4 Million Net Decrease in Assets for Q1 2026
SCOTTS MIRACLE-GRO COScotts Miracle-Gro Reports 5% Revenue Growth and Increased Net Income in Q2 Fiscal 2026
ITT INC.ITT Inc. Reports 32.7% Revenue Growth to $1.21 Billion in Q1 2026